J.W. Cole Advisors’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-3,250
| Closed | -$14K | – | 776 |
|
2022
Q3 | $14K | Buy |
3,250
+500
| +18% | +$2.15K | ﹤0.01% | 724 |
|
2022
Q2 | $14K | Hold |
2,750
| – | – | ﹤0.01% | 732 |
|
2022
Q1 | $33K | Buy |
2,750
+500
| +22% | +$6K | ﹤0.01% | 800 |
|
2021
Q4 | $44K | Buy |
2,250
+750
| +50% | +$14.7K | ﹤0.01% | 826 |
|
2021
Q3 | $39K | Buy |
1,500
+125
| +9% | +$3.25K | ﹤0.01% | 470 |
|
2021
Q2 | $30K | Hold |
1,375
| – | – | ﹤0.01% | 732 |
|
2021
Q1 | $32K | Buy |
1,375
+125
| +10% | +$2.91K | ﹤0.01% | 663 |
|
2020
Q4 | $21K | Buy |
1,250
+500
| +67% | +$8.4K | ﹤0.01% | 628 |
|
2020
Q3 | $12K | Buy |
+750
| New | +$12K | ﹤0.01% | 761 |
|